KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Intangibles: 2017-2025

  • BeOne Medicines' Change in Intangibles was N/A to $20.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $44.0 million, marking a year-over-year change of. This contributed to the annual value of $4.7 million for FY2024, which is 75.86% down from last year.
  • BeOne Medicines' Change in Intangibles amounted to $20.0 million in Q2 2025, which was up 327.90% from $4.7 million recorded in Q1 2024.
  • In the past 5 years, BeOne Medicines' Change in Intangibles registered a high of $20.0 million during Q2 2025, and its lowest value of $4.7 million during Q1 2024.
  • Over the past 3 years, BeOne Medicines' median Change in Intangibles value was $9.7 million (recorded in 2023), while the average stood at $11.0 million.